The Enrichment Program is directed by Atul Bhan. In this role, Dr. Bhan will review and make recommendations for the proposed speakers and topics of the GI Seminar series, Immunology Seminar series, IBD Research Club meetings, the annual Symposium and Workshop, and the annual Current Techniques in Molecular Genetics course. He will ensure that the goals of the Enrichment Program are met, in conjunction with an oversight committee comprised of Dr. Bhan (Chair), Ramnik Xavier, Hans-Christian Reinecker, Cornelis Terhorst, and Mark Daly. In aggregate, the activities of the Enrichment Program help provide the CSIBD with both institutional and extramural identity. The Enrichment Program fortifies the Center?s research environment by introducing new information and new scientific approaches to New England-area research teams and providing an outlet for communication of advancements with the larger CSIBD and Boston-area scientific communities. The programs enhance a scientific milieu by providing constructive feedback to Center investigators and motivate and support young investigators to pursue digestive diseases research.
The specific aims of the Enrichment Program are to (1) provide a comprehensive program of education and training to members of the CSIBD; (2) ensure that investigators are aware of the latest research relevant to the overall scientific mission of the Center; and (3) foster collaboration and interaction among CSIBD investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK043351-29
Application #
9625635
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
29
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Qu, Chen; Zheng, Dandan; Li, Sai et al. (2018) Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology :
Simon, Tracey G; King, Lindsay Y; Chong, Dawn Q et al. (2018) Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology 67:1797-1806
Borren, Nienke Z; Conway, Grace; Garber, John J et al. (2018) Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases. J Crohns Colitis 12:525-531
Battistone, Maria A; Nair, Anil V; Barton, Claire R et al. (2018) Extracellular Adenosine Stimulates Vacuolar ATPase-Dependent Proton Secretion in Medullary Intercalated Cells. J Am Soc Nephrol 29:545-556
Imhann, Floris; Vich Vila, Arnau; Bonder, Marc Jan et al. (2018) Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 67:108-119
Chandradas, Sajiv; Khalili, Hamed; Ananthakrishnan, Ashwin et al. (2018) Does Obesity Influence the Risk of Clostridium difficile Infection Among Patients with Ulcerative Colitis? Dig Dis Sci 63:2445-2450
Luther, Jay; Gala, Manish; Patel, Suraj J et al. (2018) Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways. Dig Dis Sci 63:738-745
Graham, Daniel B; Luo, Chengwei; O'Connell, Daniel J et al. (2018) Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes. Nat Med 24:1762-1772
Schirmer, Melanie; Franzosa, Eric A; Lloyd-Price, Jason et al. (2018) Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol 3:337-346
Cheung, Pui W; Terlouw, Abby; Janssen, Sam Antoon et al. (2018) Inhibition of non-receptor tyrosine kinase Src induces phosphoserine 256-independent aquaporin-2 membrane accumulation. J Physiol :

Showing the most recent 10 out of 1166 publications